Aethlon Medical (NASDAQ:AEMD – Get Free Report) released its quarterly earnings data on Wednesday. The medical equipment provider reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.09, Zacks reports.
Aethlon Medical Stock Performance
AEMD stock opened at $0.67 on Thursday. The company has a 50-day moving average of $0.62 and a two-hundred day moving average of $0.47. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $1.85.
Analysts Set New Price Targets
A number of research analysts have recently commented on AEMD shares. HC Wainwright reissued a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a report on Thursday, January 30th. StockNews.com assumed coverage on Aethlon Medical in a report on Monday, January 27th. They set a “sell” rating on the stock.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Articles
- Five stocks we like better than Aethlon Medical
- Manufacturing Stocks Investing
- PayPal: Time to Strike With Shares Down Double Digits?
- What Makes a Stock a Good Dividend Stock?
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- What is a support level?
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
